Dulaglutide biosimilar (Prestige BioPharma)
度拉糖肽生物类似药（Prestige BioPharma）
Report date: 2024/10/10 10:04:53
Base Information
Drug NameDulaglutide biosimilar (Prestige BioPharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPrestige BioPharma Ltd
China Registration ClassN/A
Develop Information
Active CompaniesPrestige BioPharma Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A